Abstract:Glycyrrhizin (GL) has immunoregulatory effects on various inflammatory diseases including hepatitis and nephritis. However, the mechanisms underlying the anti-inflammatory effect of GL on renal inflammation are not fully understood. Hepatorenal syndrome (HRS) is a functional acute renal impairment that occurs in severe liver disease, and we found that kidney injury also occurs in Con A-induced experimental hepatitis in mice. We previously found that GL can alleviate Con A-induced hepatitis by regulating the expression of IL-25 in the liver. We wanted to investigate whether GL can alleviate Con A-induced nephritis by regulating IL-25. IL-25 regulates inflammation by modulating type 2 immune responses, but the mechanism by which IL-25 affects kidney disease remains unclear. In this study, we found that the administration of GL enhanced the expression of IL-25 in renal tissues; the latter promoted the generation of type 2 macrophages (M2), which inhibited inflammation in the kidney caused by Con A challenge. IL-25 promoted the secretion of the inhibitory cytokine IL-10 by macrophages but inhibited the expression of the inflammatory cytokine IL-1β by macrophages. Moreover, IL-25 downregulated the Con A-mediated expression of Toll-like receptor (TLR) 4 on macrophages. By comparing the roles of TLR2 and TLR4, we found that TLR4 is required for the immunoregulatory effect of IL-25 on macrophages. Our data revealed that GL has anti-inflammatory effects on Con A-induced kidney injury and that the GL/IL-25/M2 axis participates in the anti-inflammatory process. This study suggested that GL is a potential therapeutic for protecting against acute kidney injury.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether glycyrrhizin (GL) can alleviate Con A - induced nephritis in mice by regulating the IL - 25/M2 axis. Specifically, the study aims to explore the effect of glycyrrhizin on Con A - induced kidney inflammation and its underlying mechanism, especially by enhancing the expression of IL - 25 to promote the polarization of M2 - type macrophages, thereby exerting an anti - inflammatory effect. ### Research Background - **Hepatorenal syndrome (HRS)**: This is a functional acute renal function impairment that occurs in patients with severe liver diseases. - **Con A - induced hepatitis model**: Con A is a substance that can activate T lymphocytes and is often used to induce liver damage in mice. Studies have found that Con A can cause not only liver inflammation but also kidney damage. - **Glycyrrhizin (GL)**: A compound extracted from licorice, which has anti - inflammatory and antiviral effects and has been clinically used to treat various inflammatory diseases, especially for treating chronic hepatitis B in Japan. ### Research Objectives - **To explore the effect of glycyrrhizin on Con A - induced nephritis**: Researchers hope to verify whether glycyrrhizin can alleviate kidney inflammation caused by Con A by regulating the expression of IL - 25. - **To reveal the mechanism of action of IL - 25**: IL - 25 controls inflammation by regulating type 2 immune responses, but its specific mechanism in kidney diseases is still unclear. Researchers hope to clarify through experiments how IL - 25 affects kidney inflammation. ### Main Findings - **Glycyrrhizin alleviates Con A - induced kidney inflammation**: Through pathological analysis and biochemical index detection, it was found that glycyrrhizin can significantly alleviate kidney damage caused by Con A. - **Glycyrrhizin enhances the expression of IL - 25**: Glycyrrhizin can increase the expression of IL - 25 in kidney tissue, and IL - 25 further promotes the generation of M2 - type macrophages. - **IL - 25 exerts an anti - inflammatory effect by regulating macrophage polarization**: IL - 25 can inhibit the expression of the pro - inflammatory cytokine IL - 1β and promote the secretion of the anti - inflammatory cytokine IL - 10. In addition, IL - 25 can also down - regulate the expression of TLR4, thereby reducing the activation of M1 - type macrophages. - **TLR4 plays a key role in the anti - inflammatory effect mediated by IL - 25**: By using TLR4 - deficient mice, researchers found that TLR4 is necessary for IL - 25 to promote the polarization of M2 - type macrophages. ### Conclusion This study shows that glycyrrhizin alleviates Con A - induced kidney inflammation by enhancing the expression of IL - 25 and promoting the generation of M2 - type macrophages. This finding provides a theoretical basis for glycyrrhizin as a potential therapeutic drug for acute kidney injury.

Glycyrrhizin attenuates renal inflammation in a mouse Con A-hepatitis model via the IL-25/M2 axis

Glycyrrhizin Regulates CD4+T Cell Response During Liver Fibrogenesis Via JNK, ERK and PI3K/AKT Pathway.

Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages

Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6/STAT3-interleukin-17 signaling

TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway

Gastrodin ameliorates Concanavalin A-induced acute hepatitis via the IL6/JAK2/STAT3 pathway

Corilagin Ameliorates Con A-Induced Hepatic Injury by Restricting M1 Macrophage Polarization

Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy

Magnesium isoglycyrrhizinate ameliorates concanavalin A-induced liver injury via the p38 and JNK MAPK pathway

The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.

Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation of NKT Cells and Promoting Proliferation of Tregs

Glycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 Signaling

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating HO-1 and reducing hepatic cell autophagy

The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.

Ginsenosides Regulates Innate Immunity to Affect Immune Microenvironment of AIH Through Hippo-YAP/TAZ Signaling Pathway

Guizhi Fuling Wan ameliorates concanavalin A-induced autoimmune hepatitis in mice

Glycyrrhizin Ameliorate Ischemia Reperfusion Lung Injury through Downregulate TLR2 Signaling Cascade in Alveolar Macrophages

Huganbuzure Granule Attenuates Concanavalin-A-Induced Immune Liver Injury in Mice via Regulating the Balance of Th1/Th2/Th17/Treg Cells and Inhibiting Apoptosis

Effect of Glycyrrhizin on Cytokine Induction in Murine Monocyte Macrophage in Vitro

Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis.